Lemonade drops 11% after notorious short-seller says the stock should trade 43% below current levels

Lemonade drops 11% after notorious short-seller says the stock should trade 43% below current levels

Lemonade

Lemonade stock fell as much as 11% on Thursday after a negative tweet from notorious short-seller Citron Research.

The online-insurance platform has outpaced the market considerably since its July IPO with shares up more than 130%.

Lemonade stock boasts a market cap in excess of $9 billion and trades at almost 100-times sales. 

Sign up here for our daily newsletter, 10 Things Before the Opening Bell.

Lemonade's stock dropped as much as 11% on Thursday after Andrew Left's notorious short-selling fund, Citron  Research, predicted the online-insurance platform will fall back to $100.

Founded by Daniel Schreiber and Shai Wininger, Lemonade operates an online insurance platform that uses AI chatbots to help service customers.

Lemonade finished Wednesday at $176.64 per share, meaning that a decline to $100 would be a 43% loss.

Of course, that hasn't been the case very often of late, as short-sellers have struggled over the past few years. Misses on big bets on Tesla, Moderna, and others have cost short-bias funds billions.





In fact, short-biased funds lost over 47% through November 2020 alone, according to the HFRX Equity Hedge: Short Bias Index.

Citron acknowledged the poor performance of short-sellers over the past few years but still declared the fund would be ripping "management